Cost Sharing – MedPAC

An official website of the United States Government —

Here’s how you know

MedPAC > Our Work > Cost Sharing

Cost Sharing

Showing 1 - 10 out of 130

Mar 15, 2022 / Chapters

Chapter 12: The Medicare Advantage program: Status report and mandated report on dual-eligible special needs plans (March 2022 Report)

Research Areas:

Beneficiaries and Coverage, Private Plans, Quality

Jul 05, 2021 / Data Book

July 2021 Data Book: Health Care Spending and the Medicare Program

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2021 / Press Releases

MedPAC releases June 2021 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2021 / Reports

June 2021 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2021 / Chapters

Chapter 1: Rebalancing Medicare Advantage benchmark policy (June 2021 report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Mar 15, 2021 / Chapters

Chapter 14: Telehealth in Medicare after the coronavirus public health emergency (March 2021 Report)

Research Areas:

Beneficiaries and Coverage, Medicare Spending and Financing, Quality

Mar 15, 2021 / Chapters

Chapter 13: The Medicare prescription drug program (Part D): Status report (March 2021 Report)

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing